The SEQTEST Procedure |

Chang, M. N. (1989), "Confidence Intervals for a Normal Mean Following a Group Sequential Test,"

*Biometrics*, 45, 247–254.Chang, M. N., Gould, A. L., and Snapinn, S. M. (1995), "P-values for Group Sequential Testing,"

*Biometrika*, 82, 650–654.Chow, S. C. and Liu, J. P. (1998),

*Design and Analysis of Clinical Trials, Concept and Methodologies,*New York: John Wiley & Sons.Chow, S. C., Shao, J., and Wang, H. (2003),

*Sample Size Calculations in Clinical Research,*Boca Raton, FL: CRC Press.Cox, E. R. (1972), "Regression Models and Life-Tables (with Discussion),"

*Journal of the Royal Statistical Society, B*, 34, 187–220.Cui, L., Hung, H. M. J., and Wang, S. (1999), "Modification of Sample Size in Group Sequential Clinical Trials,"

*Biometrics*, 55, 853–857.DeMets, D. L., Furberg, C. D., and Friedman, L. M. (2006),

*Data Monitoring in Clinical Trials,*New York: Springer.Dmitrienko, A., Molenberghs, G., Chuang-Stein, C., and Offen, W. (2005),

*Analysis of Clinical Trials Using SAS: A Practical Guide,*Cary, NC: SAS Institute Inc.Ellenberg, S. S., Fleming, T. R., and DeMets, D. L. (2003),

*Data Monitoring Committees in Clinical Trials,*New York: John Wiley & Sons.Emerson, S. S. (1996), "Statistical Packages for Group Sequential Methods,"

*The American Statistician*, 50, 183–192.Emerson, S. S. and Fleming, T. R. (1989), "Symmetric Group Sequential Designs,"

*Biometrics*, 45, 905–923.Emerson, S. S. and Fleming, T. R. (1990), "Parameter Estimation Following Group Sequential Hypothesis Testing,"

*Biometrika*, 77, 875–892.Emerson, S. S., Kittelson, J. M., and Gillen, D. L. (2005), "On the Use of Stochastic Curtailment in Group Sequential Clinical Trials,"

*UW Biostatistics Working Paper Series*,*http://www.bepress.com/uwbiostat/paper243*.Fairbanks, K. and Madsen, R. (1982), "P Values for Tests Using a Repeated Significance Test Design,"

*Biometrika*, 69, 69–74.Food and Drug Administration (1998), "E9: Statistical Principles for Clinical Trials,"

*Federal Register*, 63 (179), 49583–49598.Herson, J. (1979), "Predictive Probability Early Termination for Phase II Clinical Trials,"

*Biometrics*, 35, 775–783.Hwang, I. K., Shih, W. J., and DeCani, J. S. (1990), "Group Sequential Designs Using a Family of Type I Error Probability Spending Functions,"

*Statistics in Medicine*, 9, 1439–1445.Jennison, C. and Turnbull, B. W. (2000),

*Group Sequential Methods with Applications to Clinical Trials,*New York: Chapman & Hall.Kim, K. and Tsiatis, A. A. (1990), "Study Duration for Clinical Trials with Survival Response and Early Stopping Rule,"

*Biometrics*, 46, 81–92.Kittelson, J. M. and Emerson, S. S. (1999), "A Unifying Family of Group Sequential Test Designs,"

*Biometrics*, 55, 874–882.Lan, K. K. G. and DeMets, D. L. (1983), "Discrete Sequential Boundaries for Clinical Trials,"

*Biometrika*, 70, 659–663.Lan, K. K. G., Lachin, J. M., and Bautista, O. (2003), "Over-ruling a Group Sequential Boundary: A Stopping Rule versus a Guideline,"

*Statistics in Medicine*, 22, 3347–3355.Lan, K. K. G., Simon, R., and Halperin, M. (1982), "Stochastically Curtailed Tests in Long-Term Clinical Trials,"

*Sequential Analysis*, 1, 207–219.McCullagh, P. and Nelder, J. A. (1989),

*Generalized Linear Models,*Second Edition, New York: Chapman & Hall/CRC.Mehta, C. R. and Tsiatis, A. A. (2001), "Flexible Sample Size Considerations under Information Based Interim Monitoring,"

*Drug Information Journal*, 35, 1095–1112.O’Brien, P. C. and Fleming, T. R. (1979), "A Multiple Testing Procedure for Clinical Trials,"

*Biometrics*, 35, 549–556.Proschan, M. A., Lan, K. K. G., and Wittes, J. T. (2006),

*Statistical Monitoring of Clinical Trials,*New York: Springer.Rosner, G. L. and Tsiatis, A. A. (1988), "Exact Confidence Intervals Following a Group Sequential Trial: A Comparison of Methods,"

*Biometrika*, 75, 723–729.Rudser, K.D. and Emerson, S.S. (2007), "Implementing Type I & Type II Error Spending for Two-Sided Group Sequential Designs,"

*Contemporary Clinical Trials*, doi:10.1016/j.cct.2007.09.002.Scharfstein, D. O. and Tsiatis, A. A. (1998), "The Use of Simulation and Bootstrap in Information-Based Group Sequential Studies,"

*Statistics in Medicine*, 17, 75–87.Tsiatis, A. A. and Mehta C. R. (2003), "On the Inefficiency of the Adaptive Design for Monitoring Clinical Trials,"

*Biometrika*, 90, 367–378.Tsiatis, A. A., Rosner G. L., and Mehta C. R. (1984), "Exact Confidence Intervals Following a Group Sequential Test,"

*Biometrics*, 40, 797–803.Ware, J. H., Muller, J. E., and Braunwald, E. (1985), "The Futility Index: An Approach to the Cost-Effective Termination of Randomized Clinical Trials"

*American Journal of Medicine*, 78, 635–643.Whitehead, J. (1997),

*The Design and Analysis of Sequential Clinical Trials,*Revised Second Edition, Chichester: John Wiley & Sons.

Copyright © SAS Institute, Inc. All Rights Reserved.